DDD Partners’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $880K | Buy |
36,142
+401
| +1% | +$9.76K | 0.09% | 64 |
|
|
2025
Q1 | $742K | Buy |
35,741
+7,294
| +26% | +$151K | 0.09% | 62 |
|
|
2024
Q4 | $670K | Sell |
28,447
-126,370
| -82% | -$2.98M | 0.08% | 63 |
|
|
2024
Q3 | $3.96M | Sell |
154,817
-2,113
| -1% | -$54.1K | 0.43% | 40 |
|
|
2024
Q2 | $3.68M | Sell |
156,930
-2,342
| -1% | -$55K | 0.43% | 42 |
|
|
2024
Q1 | $4.58M | Sell |
159,272
-2,456
| -2% | -$70.6K | 0.56% | 39 |
|
|
2023
Q4 | $5.31M | Sell |
161,728
-2,744
| -2% | -$90K | 0.71% | 38 |
|
|
2023
Q3 | $4.12M | Sell |
164,472
-17,170
| -9% | -$430K | 0.59% | 39 |
|
|
2023
Q2 | $6.19M | Buy |
181,642
+605
| +0.3% | +$20.6K | 0.86% | 38 |
|
|
2023
Q1 | $5.44M | Sell |
181,037
-3,250
| -2% | -$97.7K | 0.85% | 37 |
|
|
2022
Q4 | $5.2M | Buy |
184,287
+1,332
| +0.7% | +$37.6K | 0.83% | 33 |
|
|
2022
Q3 | $6.01M | Buy |
182,955
+1,838
| +1% | +$60.4K | 1.09% | 33 |
|
|
2022
Q2 | $5.7M | Buy |
+181,117
| New | +$5.7M | 0.99% | 29 |
|